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ABSTRACT
Introduction and objective The Western diet that 
comprises high levels of long- chain saturated fats and 
sugar is associated not only with metabolic disorders 
such as obesity and type 2 diabetes but also has been 
recently linked to brain changes and cognitive dysfunction. 
However, in animal studies, reported effects are variable, 
and the mechanisms underlying these effects are 
unclear. In the proposed review, we aim to summarise the 
diverse evidence of the effects of so- called ‘high- fat’ and 
ketogenic diets on behavioural measures of cognition in 
postweaning mice and rats, relative to animals on standard 
diets and to determine potential underlying mechanisms of 
high- fat diet- induced effects.
Search strategy A comprehensive search strategy was 
designed to retrieve studies reporting use of a high- fat or 
ketogenic diet in postweaning mice and rats that included 
cognitive assessments. Three databases (Medline, SCOPUS 
and Web of Science) were searched and 4487 unique 
references were retrieved.
Screening and annotation Studies were screened for 
inclusion by two independent reviewers, with 330 studies 
retained for analysis. Characteristics of disease model 
choice, experimental design, intervention use and outcome 
assessment are to be extracted using the Systematic 
Review Facility (http:// syrf. org. uk/) tool. Studies will be 
assessed for study quality and risk of bias and confidence 
of mechanistic involvement.
Data management and reporting For cognitive outcomes, 
effect sizes will be calculated using normalised mean 
difference and summarised using a random effects model. 
The contribution of potential sources of heterogeneity to 
the observed effects of diet on cognition will be assessed 
using multivariable meta- regression, with partitioning 
of heterogeneity as a sensitivity analysis. A preliminary 
version of this protocol was published on 9 April 2019 on 
the Collaborative Approach to Meta- Analysis and Review 
of Animal Data from Experimental Studies website (http://
www. dcn. ed. ac. uk/ camarades/ research. html# protocols).
Ethics and dissemination No ethical approval is required 
as there are no subjects in the proposed study.
INTRODUCTION
The incidence of diseases associated with 
lifestyle factors such as diet has been 
steadily increasing over the last few decades 
and poses a significant global healthcare 
burden.1 2 Western diets, typically high in 
long- chain saturated fats and refined carbo-
hydrates, are linked with the development 
of metabolic dysfunction characterised by 
obesity, hypertension and insulin resistance.3 4 
This is termed the metabolic syndrome and 
places individuals at increased risk of disor-
ders including type 2 diabetes mellitus and 
cardiovascular disease.5–7 Recent evidence 
suggests that consumption of a Western diet 
may also be associated with cognitive impair-
ment and changes to brain structure and 
function. Impaired cognition appears to 
be more common, and more pronounced, 
in people with obesity8 9 or type 2 diabetes 
mellitus.10 11 12 The consumption of a Western 
diet has been associated with the develop-
ment of dementia including Alzheimer’s 
disease,13 14 and metabolic syndrome itself is 
an identified risk factor for the condition.15 In 
Strengths and limitations of this study
 ► This systematic review will comprehensively col-
lect and analyse available evidence relating to the 
effects of dietary fats on cognition as well as sum-
marising proposed underlying mechanisms.
 ► Due to differences in study findings, proposed 
mechanisms as well as experimental design, a 
comprehensive summary will be of great benefit to 
the field.
 ► This review will have a strong emphasis on evalu-
ating study design, risk of bias and strength of evi-
dence provided by included studies.
 ► An earlier version of the protocol for this study 
was registered with the Collaborative Approach 
to Meta- Analysis and Review of Animal Data from 
Experimental Studies facility.
 ► A large degree of heterogeneity in diets, animal 
models and experimental design used in included 
studies may limit our ability to summarise the overall 
effects of diet on cognition and potential underlying 
mechanisms.
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the Baltimore Longitudinal Study of Ageing, cognitively 
normal individuals with metabolic syndrome did not have 
increased cerebral amyloid (determined using Pittsburgh 
compound B (PiB) Positron Emission Tomography (PET) 
neuroimaging) at baseline when compared with patients 
without the metabolic syndrome, but the rate of accu-
mulation of cerebral amyloid in the following 2.6 years 
was higher in PiB PET- positive persons with metabolic 
syndrome than in PiB positive persons without metabolic 
syndrome; and these changes were more pronounced in 
brain regions associated with the early stages of Alzheim-
er’s disease.16 However, studies in the Lothian Birth 
Cohort17 suggest that the association between body mass 
index and impaired cognition in adults could be largely 
explained by differences in childhood IQ and socioeco-
nomic factors.
It is therefore not clear whether metabolic syndrome 
causes an increased incidence of cognitive decline in 
later life and a more rapid progression of a pre- existing 
cognitive decline; or whether metabolic syndrome and 
cognitive decline are independent but share risk factors. 
Because of the increasing numbers of those affected by 
metabolic disorders and cognitive impairment,1 18 under-
standing dietary effects on cognition and the mechanisms 
that subserve these effects is of critical importance for 
human health.
Most preclinical studies have focused on the effects 
of dietary fat and carbohydrate, alone or in combina-
tion, and this systematic review will particularly focus on 
describing the effects of dietary fat on cognitive function 
in mice and rats and the potential mechanisms of any 
effect. The scope of our systematic review is restricted to 
the study of mice and rats, to limit between- study hetero-
geneity. Many rodent studies suggest that the consump-
tion of a diet high in fat (a ‘high- fat diet’) and refined 
sugars leads to cognitive deficits, confirming effects 
observed in human studies. Diet- induced cognitive defi-
cits in rodent models have been reported in various 
learning and memory tasks,19–23 though reported effects 
often vary between studies.24 Preclinical research addi-
tionally supplies more detailed information about poten-
tial central mechanisms involved in these effects. Rodent 
studies have shown that consumption of a high- fat diet 
associated with cognitive impairment is linked to brain 
inflammation, causing increased levels of proinflamma-
tory cytokines and immune cell activation.19 25 26 Oxida-
tive stress has also been shown to occur in the brains of 
high- fat- fed rodents and cognitive impairment to be allevi-
ated by the administration of antioxidant treatments.27 28 
Moreover, high- fat diet- induced cognitive impairments 
have been linked to deficits in insulin signalling and 
brain insulin resistance29 30 as well as changes to synaptic 
plasticity,31 including alterations to neurotrophic factors 
such as Brain- Derived Neurotrophic Factor (BDNF).32
Interpretation of observed effects of high- fat diets on 
cognition or potential underlying mechanisms may not be 
straightforward if there is heterogeneity in experimental 
designs and in the definition and description of the 
dietary interventions. Various terms are used to describe 
diets with high(er) levels of fat including ‘high- fat diets’, 
‘Western diets’, ‘high- fat- sugar diets’, ‘high- energy diets’ 
or ‘cafeteria diets’. The exact composition of these diets 
and the control diets used, for instance, the content and 
types of fats and carbohydrates, may be variable and not 
completely defined. It is not known whether effects vary 
when using different species, strains and ages of experi-
mental animals or the impact of varying key experimental 
parameters such as duration of diet exposure and type 
of behaviour assessments employed.24 33 Finally, in other 
fields, low levels of measures to reduce the risks of bias 
have been reported in in vivo research,34 35 and that lower 
reporting is associated with larger estimates of biological 
effect. The extent to which in vivo research on the impact 
of dietary fat intake on cognition might be similarly 
affected is not known.
Of particular interest are studies of the effect of high- fat 
diets with very low levels of carbohydrates. These are 
referred to as ketogenic diets as they induce the produc-
tion of ketone bodies from fat (ketogenesis) as an alterna-
tive energy source to glucose36 and have been suggested 
as therapies for a number of conditions.37 38 Studies vari-
ously suggest that in animals, ketogenic diets are neuro-
protective and boost cognition39 or are detrimental to 
brain function.40
Our understanding of the effects of dietary fat on 
brain function would be enhanced by a comprehensive 
summary of in vivo research. Here we present a protocol 
for a systematic review and meta- analysis of the effects of 
diet composition, particularly fat, on cognitive function 
in mice and rats, and of the available evidence regarding 
potential underlying mechanisms. We will evaluate 
heterogeneity in study designs and dietary manipulations 
and assess reporting of measures to reduce the risk of bias 
as well as assessing the presence of possible publication 
bias.
METHODS
An earlier version of this protocol has been published (9 
April 2019) online.41
Research question and search strategy
This systematic review aims to describe the reported 
effects of manipulations of dietary fat on cognition in 
mice and rats and to review and assess the evidence for the 
mechanisms of these effects. The effects of high- fat diets 
on cognition will be determined by extracting outcome 
data in behavioural tests of cognition. Detailed study 
characteristics (animal and diet characteristics, interven-
tion, experimental design, outcome assessment) will be 
collected and analysed, and their impact on outcome 
measures will be assessed. We also aim to assess study 
quality and measures to limit risk of bias and to evaluate 
the impact of these on reported results. Specific ques-
tions are summarised in box 1.
copyright.









cience: first published as 10.1136/bm






 3Ramage FJ, et al. BMJ Open Science 2020;4:e100108. doi:10.1136/bmjos-2020-100108
Open access
The primary research questions were formulated as a 
PICO (Patient - Intervention - Comparator - Outcome) 
framework42:
Population of interest: postweaning mice and rats
Intervention: any manipulation of dietary fat
Control population: animals fed a standard diet
Outcome measures: behavioural measures of cognitive 
performance.
We designed a search strategy for Medline via PubMed, 
SCOPUS and Web of Science using published guide-
lines43 (table 1).
Study selection and inclusion/exclusion criteria
All primary research articles were included, with no 
date restrictions, which described the effect of manip-
ulation of dietary fat on cognitive outcomes in rats and 
mice with or without use of an intervention intended 
to moderate cognition, where the dietary manipulation 
occurred after weaning. Exclusion criteria were studies 
in languages other than English, where full text was not 
available (despite attempts to contact the author); review 
articles, systematic reviews, book chapters and confer-
ence abstracts; those involving animals with comorbid-
ities other than those induced by diet (including trans-
genic animals, unless the impact of transgenesis on the 
effect of diet was the objective of the study), where the 
dietary intervention was maternal or paternal or occurred 
preweaning and where the only reported outcomes were 
Box 1 Summary of research questions to be addressed in 
the systematic review
What are the effects of manipulations of dietary fat on cognition in 
otherwise healthy mice and rats?
What are the possible mechanisms underlying these effects?
If there is heterogeneity in reported findings, can this be accounted for 
by identifiable differences between experiments?
What is the heterogeneity in experimental characteristics and the 
quality of their reporting?
What is the prevalence of reporting of measures to reduce risks of 
bias?
Does reporting of measures to reduce the risk of bias explain any of 
the observed heterogeneity?
Is there evidence of publication bias?
What is the strength of evidence for causal relationships between 
individual proposed mechanisms of action and observed cognitive 
change?
Table 1 Keywords used in comprehensive search in Medline (PubMed), SCOPUS and Web of Science electronic databases
Database Search terms
Medline “High- fat diet” [MeSH] OR “high- fat diet” [tiab] OR “HFD” [tiab] OR “western diet” [tiab] OR “cafeteria 
diet” [tiab] OR “obesogenic diet” [tiab] OR “diet induced obesity” [tiab] OR “high fat- sugar diet” [tiab] 
OR “high fat high sucrose” [tiab] OR “high fat high fructose” [tiab] OR “long- chain saturated fats” 
[tiab] OR “high- lipid diet” [tiab] OR “high- fat fed” [tiab] OR “HFHS” [tiab] OR “high- energy diet” [tiab] 
OR “ketogenic diet” [MeSH] OR “ketogenic diet” [tiab] OR “very low carbohydrate diet” [tiab] OR 
“VLCD” [tiab] OR “low carbohydrate diet” [tiab] OR “carbohydrate- restricted diet” [tiab] OR “restricted 
carbohydrate diet” [tiab] OR “low- carbohydrate high- fat diet” [tiab] OR “high- fat low- carbohydrate diet” 
[tiab)
#1
mice [MeSH] OR mice [tiab] mouse [tiab] OR rat [MeSH] OR rat [tiab] OR rats [tiab] OR murine [tiab] OR 
mus [tiab] OR rattus [tiab] OR rodent [tiab)
#2
(Cognitive [tiab] OR executive [tiab)) AND (function [tiab] OR dysfunction [tiab] OR performance [tiab] OR 
deficits [tiab] OR deficit [tiab] OR rigidity [tiab] OR flexibility [tiab))) OR behaviour [tiab] OR behavior [tiab] 
OR behavioural [tiab] OR behavioral [tiab] OR memory [tiab] OR learning [tiab] OR “task performance” 
[tiab] OR cognition [tiab] OR “neural activity” [tiab] OR “brain activity” [tiab] OR “neuronal activity” [tiab] 
OR “neuro- behavioural” [tiab] OR neurological [tiab] OR ((spatial [tiab] OR episodic [tiab] OR executive 
[tiab] OR recognition [tiab)) AND (memory [tiab] OR task [tiab] OR function [tiab))) OR “synaptic plasticity” 
[tiab] OR neuroplasticity [tiab] OR “neural plasticity” [tiab] OR “long- term potentiation” [tiab] OR “long- 
term depression” [tiab] OR LTP [tiab]
#3
SCOPUS 
and Web of 
Science
“high fat diet” OR “HFD” OR “western diet” OR “cafeteria diet” OR “obesogenic diet” OR “diet induced 
obesity” OR “high fat sugar diet” OR “high fat high sucrose” OR “high fat high fructose” OR “long 
chain saturated fats” OR “high lipid diet” OR “HFHS” OR “high energy diet” OR “ketogenic diet” 
OR “ketogenic diet” OR “very low carbohydrate diet” OR “VLCD” OR “low carbohydrate diet” OR 
“carbohydrate restricted diet” OR “restricted carbohydrate diet” OR “low carbohydrate high- fat diet” OR 
“high fat low carbohydrate diet”
#1
mice OR mouse OR rat OR rat OR rats OR murine OR mus OR rattus OR rodent #2
((cognitive OR executive) AND (function OR dysfunction OR performance OR deficits OR deficit OR 
rigidity OR flexibility)) OR behaviour OR behavior OR behavioural OR behavioral OR memory OR learning 
OR “task performance” OR cognition OR “neural activity” OR “brain activity” OR “neuronal activity” 
OR “neuro- behavioural” OR neurological OR ((spatial OR episodic OR executive OR recognition) AND 
(memory OR task OR function)) OR “synaptic plasticity” OR neuroplasticity OR “neural plasticity” OR 
“long- term potentiation” OR “long- term depression” OR ltp
#3
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measures of anxiety and depression, locomotor activity, 
feeding behaviour, addiction or social behaviours.
The first version of the protocol41 proposed to include 
studies where the dietary intervention started when 
animals were at least 12- week old and had finished the 
period of rapid growth. However, during the screening 
process (see below), it was found that many studies used 
younger animals, and on reflection, it was considered that 
dietary modification in early life, but after weaning, was of 
biological importance and of interest for the review; the 
inclusion criteria were therefore amended accordingly.
Studies were screened in two stages. First, two indepen-
dent reviewers (FJR and ASC) screened studies based on 
title and abstract, and full texts of remaining articles were 
retrieved. The inclusion and exclusion criteria were then 
reapplied, by the same reviewers, with differences resolved 
in discussion with a third reviewer (RFL). Screening was 
conducted manually using EndNote V.X9.
Collection of study characteristics
Qualitative and quantitative data will be extracted using 
the Systematic Review and Meta- analysis Facility (SyRF) 
platform (http:// syrf. org. uk/). Included studies will 
be imported to the SyRF platform ( app. syrf. org. uk) for 
annotation and outcome data extraction. Annotations 
include characteristics of (1) animals (species, strain, age, 
weight, sex), (2) control and experimental diets (fat and 
carbohydrate content, detailed macronutrient compo-
sition, feeding method), (3) intervention (name, dose, 
administration route, duration/schedule of administra-
tion, type/category, proposed mechanism of action), (4) 
of experimental designs (age at diet introduction, dura-
tion of diet exposure, timing of intervention administra-
tion relative to diet), (5) cognitive outcomes measured 
(behaviour task used, timing of outcome assessment rela-
tive to diet/intervention administration, exact descrip-
tion of outcome assessment method) and (6) details of 
metabolic (eg, body weight and composition, insulin 
sensitivity) and neuropathological (eg, changes to brain 
markers or neuronal activity) outcomes reported.
Study quality appraisal and risk of bias
Study quality will be evaluated using a checklist based on 
the Collaborative Approach to Meta- Analysis and Review 
of Animal Data from Experimental Studies study quality 
checklist,44 being
i. Publication in a peer- reviewed journal.
ii. Declaration of potential conflicts of interest.
iii. Statement of compliance with animal welfare 
regulations.
iv. Appropriately detailed reporting of basic animal and 
housing characteristics and
v. Appropriate statistical power/sample size 
calculations.
In addition, domain- specific features will be consid-
ered, being
i. Whether the study measures food intake and reports 
this for each group (to ensure that effects on outcome 
are not due to differences in food intake rather than 
diet composition).
ii. Reporting of any additional experimental manipu-
lations that could have interfered with the measure-
ment of primary and secondary outcomes (such as 
the use of fasting for intraperitoneal glucose or in-
sulin tolerance tests or the use of food reward- based 
or stressful behavioural tests that may confound the 
effect of diet).
iii. Evaluation of possible confounding factors for cogni-
tive outcome measures (eg, total object exploration 
time or swimming speed).
iv. The nature of the control intervention (adequately 
matched to the intervention, rather than the absence 
of intervention).
v. The nature of the control diet and whether it is ade-
quately matched to the experimental diet.
vi. Appropriate statistical analysis and
vii. Whether any interventions might have interfered 
with the establishment of the disease model (if they 
were administered prior to the establishment of the 
high- fat diet model, ie, prior to animals having con-
sumed experimental diets for 12 weeks).
Risks of bias will be assessed using a modified version 
of the risk of bias tool proposed by SYRCLE (SYstematic 
Review Center for Laboratory animal Experimentation)
i. Selection bias
a. Were animals randomised to diet/treatment 
groups?
b. Was this group allocation adequately concealed?
c. Were baseline differences between groups as-
sessed?
i. If differences were present, were adequate ad-
justments made to account for this?
ii. Could these have influenced outcome?
ii. Performance bias
a. Was allocation to home cage randomised?
b. Were animal technicians blinded to group alloca-
tion?
c. Were researchers blinded to group allocation?
iii. Detection bias
a. Where not every animal had every outcome meas-
ured, were animals selected randomly for outcome 
assessment?
b. Was the outcome assessor blinded to diet/treat-
ment group?
iv. Attrition bias
a. Were any animals excluded from the analysis (at-
trition)?
b. Were reasons for exclusion adequately described?
v. Reporting bias
a. Was there any evidence to suggest selective out-
come reporting?
vi. Other
a. Is the unit of analysis appropriate (ie, is there evi-
dence of pseudoreplication?).
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Certainty of evidence
A secondary objective is to evaluate the possible mech-
anisms of diet- induced cognitive change. Mechanisms 
potentially involved will be inferred based on effective-
ness of different therapeutic interventions on cognitive 
performance and the effects of dietary manipulation or 
interventions on secondary neuropathological or meta-
bolic outcomes. Different studies will provide evidence of 
different strength, and confidence in the claims made as 
well as the overall quality of provided evidence, will be 
evaluated using a modified GRADE45 (Grading of Recom-
mendations, Assessment, Development and Evaluation) 
approach. Specifically, the following points will be consid-
ered:
i. Was the intervention tested in a control group and 
did it affect primary or secondary outcomes in this 
group?
ii. If the study used an intervention did the study con-
firm the effect of the intervention on the proposed 
target or mechanism of action?
iii. Were any secondary neuropathological or metabol-
ic outcomes compared for statistical correlation with 
cognitive outcome measures?
iv. Does the study present any in vitro or mechanistic 
data relevant to the hypothesis?
v. Does the study refer to or present any replications 
(technical, biological, conceptual) of the same 
experiment?
vi. Was the intervention tested at several different doses 
and was there a dose- dependent effect?
Additionally, confidence in results will be increased 
for studies with large magnitude of effect. Confidence 
will be decreased by low study quality, high risks of bias, 
inconsistency of findings and imprecision (large confi-
dence intervals). Given the expected heterogeneity in the 
circumstances of experimental evaluation, heterogeneity 
of observed effects will not reduce confidence in the find-
ings presented.
Extraction of outcome data
Outcome data will be extracted for behavioural tests 
measuring cognitive ability. This will include tests of 
learning and spatial (eg, Morris water maze, Y- maze) 
and non- spatial (eg, novel object recognition) memory 
as well as tests of executive function. The effects of diet 
on measures of locomotor activity, anxiety and depres-
sion behaviours, social behaviours, motivation or feeding 
behaviours are not within the scope of this review. Non- 
cognitive components of eligible cognitive tasks (eg, swim 
speed for Morris water maze, total object exploration 
time for novel object recognition) will also not be quan-
titatively assessed. The effects of diet on cognition will be 
determined by comparisons in task performance between 
high- fat and standard diet groups and the effects of inter-
ventions on cognition determined by comparing inter-
vention and control groups in animals fed a high- fat diet.
For each outcome reported, the number of animals 
used in the experiment, the outcome in each group 
(mean or median) and the reported variance (SD or SE 
of the mean) will be recorded. Where cognitive outcomes 
have multiple components, each component will be 
recorded, noting that these have been measured in the 
same cohort of animals at the same timepoint. Quantita-
tive data will be extracted from text or data tables or from 
figures using either a digital ruler tool or the embedded 
SyRF Graph2Data tool if available. Where all data cannot 
be ascertained, authors will be contacted for further 
information. Where sufficient data are not available, the 
data point will be excluded from analysis. Missing values 
will not be imputed.
Quantitative analysis
(1) The effects of dietary manipulation on cognition and 
(2) the effect of experimental interventions in moder-
ating the effects of dietary fat manipulation on cognition 
will be considered separately. Standardised mean differ-
ence estimates of effect size46 are associated with reduced 
meta- analytical power when group sizes are small47 but 
normalised mean difference (NMD) estimates of effect 
size are not always feasible. Therefore, NMD effect size 
estimates will be used unless this would lead to a loss of 
information of 30% or more (ie, unless NMD estimates 
are not feasible for at least 70% of effect sizes). Findings 
will be summarised using random effects meta- analysis 
performed using the SyRF R- shiny app using the restricted 
maximum likelihood estimator of tau, presenting central 
estimates and 95%CIs.46
The contribution of potential sources of heterogeneity 
in the observed effects of diets on cognitive outcome 
measures will be assessed using multivariable meta- 
regression. The independent variables to be tested in this 
prespecified analysis are disease model characteristics 
(age, sex, dietary fat and carbohydrate content and macro-
nutrient composition); experimental design parame-
ters (behaviour task used, duration of diet exposure); 
intervention characteristics (type, proposed mechanism 
of action—ie, anti- inflammatory) and study quality and 
risk of bias measures. Given the limited statistical power 
of meta- regression, differences between groups will also 
be reported, as a sensitivity analysis, using partitioning of 
heterogeneity with appropriate Bonferroni correction to 
adjust for multiple comparisons in each of disease model 
characteristics, experimental design parameters, inter-
vention characteristics and study quality and risk of bias 
measures. Secondary (neuropathological or metabolic) 
outcomes will be evaluated using the same approach.
Finally, the possible presence of publication bias will 
be evaluated using funnel plotting, Egger regression and 
‘trim- and- fill’ analysis.
Progress to date
Search terms were applied on 9 April 2019 and updated 
on 12 February 2020. A total of 7751 studies were 
retrieved, and after removal of duplicates, 4487 articles 
were screened on the basis of title and abstract. In that 
418 progressed to the full- text screening phase and 330 
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articles were retained to be included in the review (177 
high- fat diet intervention studies, 140 high- fat diet without 
intervention and 13 ketogenic diet studies) (figure 1).
DISCUSSION
Preclinical systematic reviews are useful tools for synthe-
sising large numbers of animal studies that provide 
conflicting results. These reviews can address inconsisten-
cies, inform the design and content of future preclinical 
research as well the design of human clinical studies.48 
Animal studies can be heterogenous, employing different 
models, ages and species or strains. Diets may also be 
diverse, consisting of variable proportions and types of 
fats, carbohydrates and protein. Different behavioural 
tasks and methods of outcome assessment to measure 
cognitive performance may also be used.24 33 Summarising 
available evidence and reaching robust conclusions of the 
effects of diet composition, particularly fat, on cognition 
and the underlying mechanisms for any effects is there-
fore challenging and has not to date been systematically 
addressed in reviews of the field.
The proposed systematic review was designed to 
comprehensively describe the effects of dietary fat manip-
ulation on cognition and evaluate proposed mechanisms 
behind these effects. By collecting details of model selec-
tion and experimental design and assessing how these 
are associated with differences in cognitive outcome, we 
aim to understand better the observed heterogeneity in 
reported effects of dietary fat on cognition. For instance, 
studies have suggested that responses to high- fat diets 
may depend on the age49 and sex50 of experimental 
animals and have shown different patterns in cognitive 
impairment based on behaviour task used (eg, spatial 
vs non- spatial) and duration of exposure to diet.51–53 
Additionally, by reviewing studies using high- fat but very 
low- carbohydrate ketogenic diets, we hope to further 
understand the separate roles of fat and carbohydrate 
diet components in inducing cognitive changes. Confi-
dence in the attribution of mechanistic pathways will be 
evaluated using a GRADE approach45 method of evidence 
assessment.
Limited reporting of study design and procedures to 
minimise bias has been shown to impact outcome effect 
estimates in preclinical research44 48 and is therefore 
an important consideration in assessing the validity of 
any evidence provided. This review will adapt existing 
tools44 54 to assess study quality, risk of bias and certainty 
of evidence provided in this field. We hope therefore to 
systematically assess methodological strengths and weak-
nesses of included studies and to determine whether 
these factors impact overall results as well as critically eval-
uating the likelihood of mechanistic contributions.
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